| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | Fibrinogen_CS | 4.39e-05 | 19 | 10 | 2 | IPR020837 | |
| Domain | - | 7.08e-05 | 24 | 10 | 2 | 4.10.530.10 | |
| Domain | Fibrinogen_a/b/g_C_2 | 7.08e-05 | 24 | 10 | 2 | IPR014715 | |
| Domain | Fibrinogen_C | 8.99e-05 | 27 | 10 | 2 | PF00147 | |
| Domain | FBG | 1.04e-04 | 29 | 10 | 2 | SM00186 | |
| Domain | - | 1.11e-04 | 30 | 10 | 2 | 3.90.215.10 | |
| Domain | Fibrinogen_a/b/g_C_1 | 1.11e-04 | 30 | 10 | 2 | IPR014716 | |
| Domain | FIBRINOGEN_C_2 | 1.27e-04 | 32 | 10 | 2 | PS51406 | |
| Domain | Fibrinogen_a/b/g_C_dom | 1.27e-04 | 32 | 10 | 2 | IPR002181 | |
| Domain | FIBRINOGEN_C_1 | 1.27e-04 | 32 | 10 | 2 | PS00514 | |
| Domain | ConA-like_dom | 5.79e-03 | 219 | 10 | 2 | IPR013320 | |
| Domain | EGF | 6.64e-03 | 235 | 10 | 2 | SM00181 | |
| Domain | EGF_3 | 6.64e-03 | 235 | 10 | 2 | PS50026 | |
| Domain | EGF-like_dom | 7.42e-03 | 249 | 10 | 2 | IPR000742 | |
| Domain | EGF_1 | 7.77e-03 | 255 | 10 | 2 | PS00022 | |
| Domain | EGF-like_CS | 8.13e-03 | 261 | 10 | 2 | IPR013032 | |
| Domain | EGF_2 | 8.37e-03 | 265 | 10 | 2 | PS01186 | |
| Pathway | REACTOME_AMYLOID_FIBER_FORMATION | 1.24e-03 | 110 | 7 | 2 | M27958 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | 2.47e-02 | 1389 | 7 | 3 | MM15307 | |
| Pubmed | 5.59e-05 | 814 | 10 | 4 | 23251661 | ||
| GeneFamily | Fibrinogen C domain containing | 5.11e-05 | 25 | 8 | 2 | 554 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.05e-05 | 120 | 10 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#3_top-relative-expression-ranked_1000 | 8.86e-05 | 196 | 10 | 3 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k3_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.40e-04 | 229 | 10 | 3 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_1000_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.67e-04 | 243 | 10 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k3 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.76e-04 | 288 | 10 | 3 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | 3.60e-04 | 806 | 10 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | 3.81e-04 | 818 | 10 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_1000 | 3.96e-04 | 826 | 10 | 4 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_top-relative-expression-ranked_1000 | 3.97e-04 | 827 | 10 | 4 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.85e-04 | 349 | 10 | 3 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k1_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_1000 | 6.07e-04 | 377 | 10 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#4_top-relative-expression-ranked_500 | 7.14e-04 | 86 | 10 | 2 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k4_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_k-means-cluster#3_top-relative-expression-ranked_1000 | 7.65e-04 | 89 | 10 | 2 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_k3_1000 | |
| CoexpressionAtlas | EB bone marrow_vs_EB blastocyst-Confounder_removed-fold2.0_adjp0.05 | 9.90e-04 | 446 | 10 | 3 | PCBC_ratio_EB bone marrow_vs_EB blastocyst_cfr-2X-p05 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.53e-06 | 181 | 10 | 3 | 7af469f5bcb9b1ab3f35b2758bf2afb87e8eba57 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-matrix_-_immature_2|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.78e-04 | 113 | 10 | 2 | dc002185095590fc071b2f39259f8b87a757e174 | |
| ToppCell | LPS-IL1RA-Unknown-Endothelial-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.40e-04 | 125 | 10 | 2 | 2938a1d62afe1e0a3abba5eb92f07b886cc0accd | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.63e-04 | 146 | 10 | 2 | bb7bf20245d93c8812920dd0debbf1ed00add378 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.69e-04 | 147 | 10 | 2 | b66ccc710b3c04f6fc7fed69f3c892fc110e98fc | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.88e-04 | 150 | 10 | 2 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | AT1-AT2_cells-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 5.21e-04 | 155 | 10 | 2 | 010e45ef4b505bf419ea41e4d1619521d1c78319 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-5_VIP_KCNJ2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.48e-04 | 159 | 10 | 2 | 51a7322efead3d4978e8f9fef71302bfae96edd7 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.90e-04 | 165 | 10 | 2 | cca3ba9d7d30404e3e683b8cfd500c348a4974b9 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L3_VIP_CBLN1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.97e-04 | 166 | 10 | 2 | 688e3c01ffcec01eb7027df6f3bde8fecfb50479 | |
| ToppCell | 10x5'-lymph-node_spleen-Mast|lymph-node_spleen / Manually curated celltypes from each tissue | 6.12e-04 | 168 | 10 | 2 | e58ffbb57c81967766755c3f6f347b158a39cb0d | |
| ToppCell | 10x5'-lymph-node_spleen-Mast-Mast_cells|lymph-node_spleen / Manually curated celltypes from each tissue | 6.12e-04 | 168 | 10 | 2 | 650ad3ea52577887885d82457dbc04202ce3eb34 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_A|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.19e-04 | 169 | 10 | 2 | 606aa4ff25380d9470ec116ca86cd20f8b19587a | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-5|TCGA-Bladder / Sample_Type by Project: Shred V9 | 6.19e-04 | 169 | 10 | 2 | 9c4e83fe8225d16173a103bf5a57b17d623be923 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.19e-04 | 169 | 10 | 2 | 052aae2af5446a0de071d5dda5381b0b9a0ed54d | |
| ToppCell | Endothelial-B-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 6.41e-04 | 172 | 10 | 2 | d4e98ff9c7cbc95457e1d71fa60f151a2f178dae | |
| ToppCell | Endothelial-Endothelial-G|Endothelial / shred on cell class and cell subclass (v4) | 6.41e-04 | 172 | 10 | 2 | 644f8e42ee8d8996f6ae50cdf874559be55509fc | |
| ToppCell | Ionocyte-iono-2|World / Class top | 6.48e-04 | 173 | 10 | 2 | e5ec28ccc5e048fd98de4c876e5c53b866b66228 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-5_VIP_KCNJ2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.56e-04 | 174 | 10 | 2 | fdadac1eaab2c4a67e4832f0901df22e893add6a | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.63e-04 | 175 | 10 | 2 | f1394aacc8a94ca555dd19aaed5a18da99c6bf40 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.63e-04 | 175 | 10 | 2 | d52794426f2703a80e91ae0a8ff2d8e0ce4aa4a8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.63e-04 | 175 | 10 | 2 | 454f03e6109d65f5db08dbb41ecc19ffb6bbc4e0 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.63e-04 | 175 | 10 | 2 | 7bf1194d93fbe2dbf9d953e0a32b2a6d88251ed1 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-plasmablast-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.63e-04 | 175 | 10 | 2 | 89bf89466191da14896ed8928027f5b911436c22 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.71e-04 | 176 | 10 | 2 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 6.71e-04 | 176 | 10 | 2 | 0923b01137d6f9956ca815b41102c81e82624065 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.71e-04 | 176 | 10 | 2 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.78e-04 | 177 | 10 | 2 | 8abdf1d970b2f15e17e185f3e612dd5065c88757 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L6_LHX6_GLP1R|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.78e-04 | 177 | 10 | 2 | 5e0fca9bd5e5ffe6d39f5bcd81f36512f3b0cb1b | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.94e-04 | 179 | 10 | 2 | bfc226bcf0b93525992344f968268a261d86fcbf | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.94e-04 | 179 | 10 | 2 | 36ad18f52e175ab636ceaa3be81212fa362c96c1 | |
| ToppCell | ASK454-Endothelial-Lymphatic|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.94e-04 | 179 | 10 | 2 | fd84a79f76a01c0377dff5b20016b004d369f96f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.01e-04 | 180 | 10 | 2 | 023ec0b080c8a5cd0f36e83c6b17d4be3c01edb5 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.01e-04 | 180 | 10 | 2 | dfc75ae4395ff46fbec2c54915d98ead5a1ba1a1 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.01e-04 | 180 | 10 | 2 | f6a05b3751b01e74b2de8440801b0eb2e723c199 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.09e-04 | 181 | 10 | 2 | e898ecb8d8f2eb2204225b7b0d665cadcd241139 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.09e-04 | 181 | 10 | 2 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.09e-04 | 181 | 10 | 2 | 2f3d04d22d4ac016e61709ea5af3d48885c946c4 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.09e-04 | 181 | 10 | 2 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | droplet-Kidney-nan-3m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.09e-04 | 181 | 10 | 2 | 0b1e7335648823b1d83bdfa878ccd44efe7bba9a | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.17e-04 | 182 | 10 | 2 | 7dc61e901428cea04f00ebb0939a44d21a6145c6 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.17e-04 | 182 | 10 | 2 | 420a8fd30543e37a66ba0786215d056d308660d0 | |
| ToppCell | droplet-Heart-4Chambers-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.17e-04 | 182 | 10 | 2 | f4b74c2756989812abe4e7055ec8918f69d56025 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.25e-04 | 183 | 10 | 2 | 6e6128c5be5e0a2db6d84eecbf4dddd02d0216f8 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.25e-04 | 183 | 10 | 2 | 5e361be3ae3fe05098968e58427630127bd12675 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.25e-04 | 183 | 10 | 2 | af8d86f15a549064530d94bd47081daf59d58ecd | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.25e-04 | 183 | 10 | 2 | e3ffef2b57dc5b96466dccc9cd54ba326ccf378a | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.33e-04 | 184 | 10 | 2 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_mature|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.33e-04 | 184 | 10 | 2 | 920f95625978132c2b6c76654ef6298244103e2d | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_mature-Lymphatic_EC_mature_L.2.5.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.33e-04 | 184 | 10 | 2 | e5756afa3181186f9b65552b8df5359ef4024bee | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.33e-04 | 184 | 10 | 2 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.33e-04 | 184 | 10 | 2 | 32473dbdb2de66391157c5814ef34e790806e4f2 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.33e-04 | 184 | 10 | 2 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | droplet-Lung-1m-Mesenchymal-myofibroblast-pericyte_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.33e-04 | 184 | 10 | 2 | 39bb0eb55bdc2cea46e41c7f21d8c5883f14e6bd | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_mature-Lymphatic_EC_mature_L.2.5.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.33e-04 | 184 | 10 | 2 | 968afa6b5ba84169377a24c150bb68749fa674d9 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.33e-04 | 184 | 10 | 2 | 4cb5f299dd7413e0be1ad7af817ee614b23a18ae | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Lymphatic_EC|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.33e-04 | 184 | 10 | 2 | 15cbddea9efb2346a2028d77edfe9ba32923568f | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.33e-04 | 184 | 10 | 2 | 0087c605c161fd8a39aa394f51994a04e8353bf1 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.41e-04 | 185 | 10 | 2 | 16e9ccea0e3b95d90dc48ef74206c805681dac0b | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-04 | 185 | 10 | 2 | efcfbf5a48b3ea9a425183e5c2eec6a9585415a0 | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.41e-04 | 185 | 10 | 2 | b1e84228c95be8ccf7c3c1afb66b71ffb93cf61e | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.41e-04 | 185 | 10 | 2 | 027020754dbf71b0034791f9a34ae795e3b85f81 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.41e-04 | 185 | 10 | 2 | 08fad1e3c3cc5f1c3eb6629a49c094b628e75a92 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.41e-04 | 185 | 10 | 2 | cefd81adb480c027545a5c78dcd05669783717f4 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.41e-04 | 185 | 10 | 2 | bdfa8c284bbc5e85c806327fbb7778cf16242a38 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-04 | 185 | 10 | 2 | 642088ace9230d38b0579853c54ff4dd8b5d5df4 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-04 | 185 | 10 | 2 | f98af3146ec2f44c30d31a662fb9c4fa3ca4f706 | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.48e-04 | 186 | 10 | 2 | db9b67066fc003c7995ec205d15176bf40c97add | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.48e-04 | 186 | 10 | 2 | 20340a5b5cc7f07386498a4ef937d6fbc9e347c4 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.56e-04 | 187 | 10 | 2 | ae2ee6f8e5c37cb88a67f3e742cf86e57657bfaf | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.56e-04 | 187 | 10 | 2 | 02105c82a9ba79d2f19e002188377fc3440770c2 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.56e-04 | 187 | 10 | 2 | e93cad16a087d1443cbf4e1690dc1b35d7a84c41 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.65e-04 | 188 | 10 | 2 | 0aa8747c2931b0c91f6d78bb2db8fd8ede6dd559 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.73e-04 | 189 | 10 | 2 | f7e2ee5047792ab9ef6472fa88e2d193cdea6fa0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.73e-04 | 189 | 10 | 2 | 2cfb4d12f75678d1619f4743838a0e954bd57761 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.73e-04 | 189 | 10 | 2 | 127ad2ba3e794df8cce2eee3e4171bccb5aad51b | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.81e-04 | 190 | 10 | 2 | 591310e615700321a010a4b90405cbbbbdb3aade | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.81e-04 | 190 | 10 | 2 | 2f54da2bee411f8868348a4c37034184b8f58a89 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.81e-04 | 190 | 10 | 2 | 719a5cecc3e8001ca9c38165258b5ff9c800713a | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-GHRL+_neuroendocrine|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 7.81e-04 | 190 | 10 | 2 | b5c6f3248c0c2f648e1578457c6a729ca22bf0da | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.89e-04 | 191 | 10 | 2 | f76f3f5c7902a3659d8cbe470f96ce57c8a6744d | |
| ToppCell | facs-Tongue-nan-18m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.89e-04 | 191 | 10 | 2 | 02f24202f9fdd46c648265a5b3b6f9066aa009fc | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.89e-04 | 191 | 10 | 2 | a15e34ad7dbf3f2f13d5e23ce3ffb6d08fd1f9f0 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.97e-04 | 192 | 10 | 2 | 3abee376c37c3646da33ac381aa63d50a01607a6 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.05e-04 | 193 | 10 | 2 | 87d3a577d37fb0cb4b6313c596310de452bc3872 | |
| ToppCell | Control-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.05e-04 | 193 | 10 | 2 | aff0649c73c634bc6ff0dc7759b4693a9236bf05 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-stromal_related|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.05e-04 | 193 | 10 | 2 | f27e2be497745098b5269aa799dd3d5f62d78ba7 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.05e-04 | 193 | 10 | 2 | 146e8c148478ab61b1c1dbaf1ee98a8cd4a0ff8a | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.05e-04 | 193 | 10 | 2 | 826b8dd801298b3e0cd76232feae5a14026b8806 | |
| ToppCell | Control-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.05e-04 | 193 | 10 | 2 | c5f9fe03e64c211d4bcd4959e5b32f14841e336a | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.05e-04 | 193 | 10 | 2 | 4ccf984baebbb13ae916727137ce593fda7514a2 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.05e-04 | 193 | 10 | 2 | cf2461af78f65616ce40d552ee9452295e3895ed | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.05e-04 | 193 | 10 | 2 | a7002acf3be76b2cc6fc9364176f6b0d3bd27d9c | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.05e-04 | 193 | 10 | 2 | e4ea7ce011a80b81b841c907719aa532bed39d2e | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.05e-04 | 193 | 10 | 2 | 6ef9007c9d18fb775d08fb20cdf954a28d54d7eb | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.05e-04 | 193 | 10 | 2 | eba3c70701b051bc1ed1f4db9270cb27a77ffc3e | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.05e-04 | 193 | 10 | 2 | d485634c564b268e344b6a2863c26f6adaec9e38 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.14e-04 | 194 | 10 | 2 | 4d7d24390fdb379f943ddcc70a63f23955e10163 | |
| ToppCell | distal-Hematologic-Myeloid_Dendritic_Type_1-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.14e-04 | 194 | 10 | 2 | f0467d81063a9b19783906c456935ef8318b9b98 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.14e-04 | 194 | 10 | 2 | 43eb677a76634bb9a48a40e0d607c4936ae64bcc | |
| Drug | Hesperidin [520-26-3]; Up 200; 6.6uM; PC3; HT_HG-U133A | 1.10e-06 | 197 | 10 | 4 | 6714_UP | |
| Drug | Beta-Escin [11072-93-8]; Up 200; 3.2uM; MCF7; HT_HG-U133A | 6.78e-05 | 192 | 10 | 3 | 6050_UP | |
| Drug | Guanfacine hydrochloride [29110-48-3]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 7.10e-05 | 195 | 10 | 3 | 5256_UP | |
| Drug | PF-00562151-00 [351320-12-2]; Down 200; 10uM; PC3; HT_HG-U133A | 7.21e-05 | 196 | 10 | 3 | 6863_DN | |
| Drug | ICI182,780; Down 200; 1uM; PC3; HT_HG-U133A | 7.32e-05 | 197 | 10 | 3 | 6867_DN | |
| Drug | Neomycin sulfate [1405-10-3]; Up 200; 4.2uM; MCF7; HT_HG-U133A | 7.32e-05 | 197 | 10 | 3 | 2229_UP | |
| Drug | Flucloxacillin sodium [1847-24-1]; Up 200; 8.4uM; PC3; HT_HG-U133A | 7.43e-05 | 198 | 10 | 3 | 5102_UP | |
| Drug | Dubinidine [22964-77-8]; Down 200; 14.6uM; PC3; HT_HG-U133A | 7.66e-05 | 200 | 10 | 3 | 5774_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 2.54e-03 | 175 | 10 | 2 | 4153_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 2.68e-03 | 180 | 10 | 2 | 7236_UP | |
| Drug | Gossypol [303-45-7]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 2.68e-03 | 180 | 10 | 2 | 3637_UP | |
| Drug | Rifabutin [72559-06-9]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 2.71e-03 | 181 | 10 | 2 | 4349_UP | |
| Drug | Mycophenolic acid [24280-93-1]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 2.71e-03 | 181 | 10 | 2 | 2857_UP | |
| Drug | 15d-PGJ2; Up 200; 10uM; PC3; HT_HG-U133A | 2.77e-03 | 183 | 10 | 2 | 4455_UP | |
| Drug | Thiostrepton [1393-48-2]; Up 200; 2.4uM; HL60; HT_HG-U133A | 2.80e-03 | 184 | 10 | 2 | 2462_UP | |
| Drug | Chlorpromazine hydrochloride [69-09-0]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 2.92e-03 | 188 | 10 | 2 | 5493_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 2.92e-03 | 188 | 10 | 2 | 3177_UP | |
| Drug | troglitazone; Down 200; 10uM; HL60; HT_HG-U133A | 2.95e-03 | 189 | 10 | 2 | 2692_DN | |
| Drug | Equilin [474-86-2]; Up 200; 15uM; MCF7; HT_HG-U133A | 3.01e-03 | 191 | 10 | 2 | 3377_UP | |
| Drug | lomustine; Up 200; 100uM; PC3; HT_HG-U133A | 3.01e-03 | 191 | 10 | 2 | 7050_UP | |
| Drug | Thioperamide maleate [106243-16-7]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 3.01e-03 | 191 | 10 | 2 | 3392_UP | |
| Drug | (1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 3.01e-03 | 191 | 10 | 2 | 4367_UP | |
| Drug | Metampicillin sodium salt [6489-61-8]; Up 200; 10.4uM; PC3; HT_HG-U133A | 3.04e-03 | 192 | 10 | 2 | 2123_UP | |
| Drug | Beta-Escin [11072-93-8]; Up 200; 3.2uM; PC3; HT_HG-U133A | 3.04e-03 | 192 | 10 | 2 | 3807_UP | |
| Drug | prochlorperazine dimaleate salt; Down 200; 10uM; HL60; HT_HG-U133A | 3.08e-03 | 193 | 10 | 2 | 2675_DN | |
| Drug | cis-4,7,10,13,16,19-Docosahexaenoic acid ethyl ester; Up 200; 100uM; MCF7; HT_HG-U133A_EA | 3.08e-03 | 193 | 10 | 2 | 881_UP | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.08e-03 | 193 | 10 | 2 | 5602_DN | |
| Drug | Hydrocortisone base [50-23-7]; Up 200; 11uM; MCF7; HT_HG-U133A | 3.11e-03 | 194 | 10 | 2 | 3284_UP | |
| Drug | Thalidomide [50-35-1]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 3.11e-03 | 194 | 10 | 2 | 2258_UP | |
| Drug | Ethoxyquin [91-53-2]; Up 200; 18.4uM; MCF7; HT_HG-U133A | 3.11e-03 | 194 | 10 | 2 | 3846_UP | |
| Drug | Estrone [53-16-7]; Down 200; 14.8uM; PC3; HT_HG-U133A | 3.11e-03 | 194 | 10 | 2 | 6647_DN | |
| Drug | Carbamazepine [298-46-4]; Up 200; 17uM; PC3; HT_HG-U133A | 3.11e-03 | 194 | 10 | 2 | 1805_UP | |
| Drug | Fludrocortisone acetate [514-36-3]; Up 200; 9.4uM; PC3; HT_HG-U133A | 3.11e-03 | 194 | 10 | 2 | 3785_UP | |
| Drug | Kawain [500-64-1]; Up 200; 17.4uM; MCF7; HT_HG-U133A | 3.11e-03 | 194 | 10 | 2 | 2299_UP | |
| Drug | Methoxy-6-harmalan [3589-73-9]; Up 200; 18.6uM; MCF7; HT_HG-U133A | 3.11e-03 | 194 | 10 | 2 | 2893_UP | |
| Drug | Flunisolide [3385-03-3]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 3.14e-03 | 195 | 10 | 2 | 3828_UP | |
| Drug | Betonicine [515-25-3]; Up 200; 25.2uM; MCF7; HT_HG-U133A | 3.14e-03 | 195 | 10 | 2 | 3642_UP | |
| Drug | Phenformin hydrochloride [834-28-6]; Up 200; 16.6uM; MCF7; HT_HG-U133A | 3.14e-03 | 195 | 10 | 2 | 4747_UP | |
| Drug | radicicol; Up 200; 0.1uM; PC3; HT_HG-U133A | 3.14e-03 | 195 | 10 | 2 | 5952_UP | |
| Drug | Deoxycorticosterone [64-85-7]; Up 200; 12.2uM; HL60; HT_HG-U133A | 3.14e-03 | 195 | 10 | 2 | 3099_UP | |
| Drug | Talampicillin hydrochloride [39878-70-1]; Up 200; 7.8uM; PC3; HT_HG-U133A | 3.14e-03 | 195 | 10 | 2 | 7254_UP | |
| Drug | Testosterone propionate [57-85-2]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 3.14e-03 | 195 | 10 | 2 | 5636_UP | |
| Drug | Norethindrone [68-22-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 3.14e-03 | 195 | 10 | 2 | 5474_UP | |
| Drug | Myosmine [532-12-7]; Up 200; 27.4uM; MCF7; HT_HG-U133A | 3.14e-03 | 195 | 10 | 2 | 3634_UP | |
| Drug | Pheniramine maleate [132-20-7]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 3.17e-03 | 196 | 10 | 2 | 4130_DN | |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 3.17e-03 | 196 | 10 | 2 | 4406_UP | |
| Drug | Aminocaproic acid [60-32-2]; Up 200; 30.4uM; HL60; HT_HG-U133A | 3.17e-03 | 196 | 10 | 2 | 3122_UP | |
| Drug | Amiodarone hydrochloride [19774-82-4]; Up 200; 5.8uM; MCF7; HT_HG-U133A | 3.17e-03 | 196 | 10 | 2 | 5253_UP | |
| Drug | Rolitetracycline [751-97-3]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 3.17e-03 | 196 | 10 | 2 | 3369_UP | |
| Drug | Ketoprofen [22071-15-4]; Up 200; 15.8uM; PC3; HT_HG-U133A | 3.17e-03 | 196 | 10 | 2 | 3729_UP | |
| Drug | Pipenzolate bromide [125-51-9]; Up 200; 9.2uM; PC3; HT_HG-U133A | 3.17e-03 | 196 | 10 | 2 | 4484_UP | |
| Drug | Ceforanide [60925-61-3]; Up 200; 7.6uM; HL60; HT_HG-U133A | 3.17e-03 | 196 | 10 | 2 | 2447_UP | |
| Drug | Edrophonium chloride [116-38-1]; Up 200; 19.8uM; MCF7; HT_HG-U133A | 3.20e-03 | 197 | 10 | 2 | 5001_UP | |
| Drug | Ciprofibrate [52214-84-3]; Up 200; 13.8uM; HL60; HT_HG-U133A | 3.20e-03 | 197 | 10 | 2 | 6138_UP | |
| Drug | Ioversol [87771-40-2]; Up 200; 5uM; PC3; HT_HG-U133A | 3.20e-03 | 197 | 10 | 2 | 6726_UP | |
| Drug | Hydralazine hydrochloride [304-20-1]; Up 200; 20.4uM; MCF7; HT_HG-U133A | 3.20e-03 | 197 | 10 | 2 | 3621_UP | |
| Drug | Lisinopril [83915-83-7]; Up 200; 9uM; HL60; HT_HG-U133A | 3.20e-03 | 197 | 10 | 2 | 2371_UP | |
| Drug | Sulfameter [651-06-9]; Up 200; 14.2uM; HL60; HT_HG-U133A | 3.20e-03 | 197 | 10 | 2 | 2712_UP | |
| Drug | Ajmalicine hydrochloride [4373-34-6]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 3.20e-03 | 197 | 10 | 2 | 2898_UP | |
| Drug | 0225151-0000 [351320-15-5]; Up 200; 10uM; PC3; HT_HG-U133A | 3.20e-03 | 197 | 10 | 2 | 6389_UP | |
| Drug | Captopril [62571-86-2]; Up 200; 17.2uM; PC3; HT_HG-U133A | 3.20e-03 | 197 | 10 | 2 | 4585_UP | |
| Drug | 0173570-0000 [211245-44-2]; Up 200; 1uM; PC3; HT_HG-U133A | 3.20e-03 | 197 | 10 | 2 | 3693_UP | |
| Drug | Roxithromycin [80214-83-1]; Up 200; 4.8uM; PC3; HT_HG-U133A | 3.20e-03 | 197 | 10 | 2 | 4192_UP | |
| Drug | Pramoxine hydrochloride [637-58-1]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 3.20e-03 | 197 | 10 | 2 | 6054_UP | |
| Drug | Deltaline [6836-11-9]; Down 200; 7.8uM; PC3; HT_HG-U133A | 3.20e-03 | 197 | 10 | 2 | 3750_DN | |
| Drug | estradiol, USP; Up 200; 0.01uM; PC3; HT_HG-U133A | 3.20e-03 | 197 | 10 | 2 | 4465_UP | |
| Drug | Sulfachloropyridazine [80-32-0]; Up 200; 14uM; PC3; HT_HG-U133A | 3.20e-03 | 197 | 10 | 2 | 3769_UP | |
| Drug | Methyldopate hydrochloride [2508-79-4]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 3.20e-03 | 197 | 10 | 2 | 7360_UP | |
| Drug | Felodipine [72509-76-3]; Up 200; 10.4uM; HL60; HT_HG-U133A | 3.20e-03 | 197 | 10 | 2 | 2433_UP | |
| Drug | felodipine; Up 200; 10uM; MCF7; HG-U133A | 3.20e-03 | 197 | 10 | 2 | 337_UP | |
| Drug | CP-320650-01 [172079-28-6]; Down 200; 1uM; PC3; HT_HG-U133A | 3.20e-03 | 197 | 10 | 2 | 3825_DN | |
| Drug | Acetaminophen [103-90-2]; Up 200; 26.4uM; MCF7; HT_HG-U133A | 3.20e-03 | 197 | 10 | 2 | 3364_UP | |
| Drug | Solasodine [126-17-0]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 3.20e-03 | 197 | 10 | 2 | 3924_UP | |
| Drug | Vitamin K2 [11032-49-8]; Up 200; 9uM; PC3; HT_HG-U133A | 3.20e-03 | 197 | 10 | 2 | 3798_UP | |
| Drug | Dihydrostreptomycin sulfate [5490-27-7]; Up 200; 2.8uM; MCF7; HT_HG-U133A | 3.20e-03 | 197 | 10 | 2 | 2237_UP | |
| Disease | stroke | 1.04e-03 | 144 | 10 | 2 | EFO_0000712 | |
| Disease | obesity (implicated_via_orthology) | 2.29e-03 | 215 | 10 | 2 | DOID:9970 (implicated_via_orthology) | |
| Disease | melanoma | 3.03e-03 | 248 | 10 | 2 | C0025202 | |
| Disease | coronary artery disease | 6.40e-03 | 1194 | 10 | 3 | EFO_0001645 | |
| Disease | intraocular pressure measurement | 1.22e-02 | 509 | 10 | 2 | EFO_0004695 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SNQCCNWNYFGWGEQ | 171 | Q9UPW8 | |
| CQHGGTCMDYWSWQQ | 4171 | Q6V0I7 | |
| GGWWYNACAHSNLNG | 436 | Q9UKU9 | |
| QWNYGNWGECSQTCG | 1361 | P59510 | |
| CTFEKGWCGWQNSQA | 1521 | Q5VYJ5 | |
| GGYQTDWVCGGQWNA | 131 | Q9NX05 | |
| EVYGGGWWYNNCQAA | 801 | P02671 | |
| WQQECGVQGSCWEYN | 716 | Q9H2Y9 | |
| WQCCGAFGADDWNLN | 151 | P62079 | |
| WSRGQGLWNCFCDSG | 776 | Q6ZT98 |